In the lychee forests of Lingnan, well‑known varieties such as Gua Lü, Nuomici, Feizixiao, and Xianjinfeng captivate countless palates with their unique flavors. Meanwhile, in the cell culture dishes and shake flasks of Canton Biologics' laboratories, star cell lines such as CHOZen® (CHO‑K1), CHOFlow®, and GEX® serve as “trusted assistants” in large‑molecule biologic drug development, thanks to their outstanding expression performance. Though seemingly unrelated, these two worlds actually share fascinating parallels in characteristics, advantages, and applications. Today, let us embark on this delightful journey that bridges the tip of the tongue and the microscopic realm!
Lychee “Superstars” vs. Cell Line “Stars” – A Characteristic Showdown
Gua Lü Lychee vs. CHOZen® (CHO‑K1) Cells: The Dual Charm of Rarity and Classic Excellence
Gua Lü lychee is hailed as the “King of Lychees.” It features a distinctive green mark in the middle of the fruit, is produced in very limited quantities, and has even fetched astronomical prices at auction – truly the “aristocrat” of lychees. Its flesh is crisp and refreshing, with a subtle, unique sweetness that has enchanted poets and scholars for centuries.
CHO‑K1 cells are similarly the “classic aristocrats” of cell lines. As a derivative of Chinese hamster ovary (CHO) cells, they were first established in 1957 and remain one of the most widely used cell lines in biomedicine. Canton Biologics’ proprietary CHOZen® cell line has a well‑defined genetic background, stable growth, and strong protein expression capabilities (average mAb titer of 10 g/L, up to 20 g/L). Just as Gua Lü lychee stands out for its rarity and unique taste, CHOZen® cells excel in performance, making them the top choice for the development and production of monoclonal antibodies, bispecific antibodies, recombinant protein drugs, and recombinant vaccines.
Nuomici Lychee vs. CHOFlow® Cells: A Perfect Match of Soft, Sweet Texture and High‑Efficiency Expression
Nuomici lychee is renowned for its soft, waxy, delicate texture and intensely sweet flavor. Its flesh is plump and juicy, delivering a blissful sensation with every bite – a favorite among those who seek the ultimate taste experience.
In the field of engineered cell lines for protein drugs, CHOFlow® is a worthy counterpart. CHOFlow® enables the production of monoclonal antibodies lacking core fucosylation, resulting in higher affinity for Fcγ receptors and enhanced ADCC activity. Just as Nuomici stands out among lychees for its uniquely rich and creamy taste, CHOFlow® plays a key role in antibody engineering through its specialized glycosylation modification capabilities, effectively reducing therapeutic doses and improving treatment efficiency.
Feizixiao Lychee vs. GlycoExpress® (GEX®) Cells: All‑Round Performers with Both Beauty and Brains
Feizixiao lychee features large, vibrant fruits with a striking green‑and‑red appearance that is highly recognizable. Its flavor is refreshingly sweet with a hint of tartness, offering layered complexity. It has both “good looks” and “substance,” and is highly adaptable to different growing conditions – tolerant of rough handling, easy to grow, resistant to over‑fertilization, and fond of water. This reminds us of the GEX® technology platform, which is specifically designed to address different glycosylation needs. Depending on the requirements, GEX® can flexibly adjust sialylation and fucosylation, improve galactosylation levels and branching patterns – much like Feizixiao adapts to diverse environments – to meet complex demands, giving it a broad “adaptability spectrum” in cell technology applications.
Technology Empowerment: The Parallels Between Lychee Cultivation and Cell Culture
Lychee cultivation relies on techniques such as grafting, crossbreeding, and gene editing to optimize variety traits; cell culture similarly requires technological support to maximize performance.
-
Precise Nutrient Regulation: Canton Biologics has distinctive expertise in proprietary media and upstream process development. Its self‑developed Can‑Rise™ high‑yield medium acts like a customized “nutritional meal plan” for cells, rich in amino acids, vitamins, and other key nutrients, providing an ideal environment for cell growth and proliferation. In antibody drug production, using this medium increases titers by an average of 10‑15% compared to imported brands.
In upstream process development, Canton Biologics has established an enhanced fed‑batch culture development platform (C‑Boost®). Built on traditional fed‑batch culture, this platform incorporates in‑depth medium optimization, precise feeding strategies, and innovative culture mode improvements. By precisely controlling cell growth characteristics and metabolic patterns, the platform increases cell seeding density in production bioreactors, significantly boosting expression levels – up to 150% of traditional fed‑batch culture.
-
Screening and Optimization: To preserve the signature sweet flavor of “Gui Wei” lychees, breeders must painstakingly select individual plants with stable traits from thousands of seedlings, then propagate the desirable characteristics through grafting.
Canton Biologics pursues the same extreme precision in protein screening and optimization. Its “two‑step” chromatography method for antibodies acts like a “precision protein sorter,” accomplishing purification with high efficiency. In practice, this two‑step purification technology achieves purity approaching 99%, strictly controls residual host cell protein levels below 100 ppm, delivers gram‑scale protein for R&D in just 2 weeks, and produces a robust, scalable downstream process in 2‑3 months – dramatically shortening R&D timelines and helping to accelerate emergency drug development.
Formulation Development – Customizing a “Freshness Preservation Gift Box” for Protein Drugs
To get lychees – whose freshness can deteriorate within a single day – to northern markets, Lingnan fruit growers use bamboo baskets, layers of ice, and even invent preservation methods such as soaking lychees in honey.


中文